Veru (NASDAQ:VERU - Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.06) by $0.01, Zacks reports. Veru had a negative return on equity of 112.75% and a negative net margin of 223.85%.
Veru Price Performance
Shares of VERU stock traded down $0.01 on Tuesday, reaching $0.51. 250,113 shares of the stock were exchanged, compared to its average volume of 1,737,940. The stock has a market cap of $75.04 million, a PE ratio of -1.97 and a beta of -0.74. Veru has a one year low of $0.45 and a one year high of $1.57. The stock has a 50 day moving average price of $0.53 and a 200 day moving average price of $0.63.
Insider Transactions at Veru
In other Veru news, Director Michael L. Rankowitz purchased 95,279 shares of the company's stock in a transaction that occurred on Tuesday, February 18th. The stock was acquired at an average cost of $0.55 per share, with a total value of $52,403.45. Following the completion of the purchase, the director now directly owns 195,279 shares in the company, valued at approximately $107,403.45. This represents a 95.28% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 14.90% of the stock is currently owned by corporate insiders.
Veru Company Profile
(
Get Free Report)
Veru Inc, a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and acute respiratory distress syndrome (ARDS). Its marketed products comprise FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections.
Featured Stories
Before you consider Veru, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veru wasn't on the list.
While Veru currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
